Johnson & Johnson to spin off its consumer-healthcare business at $40B valuation – WSJ

Johnson & Johnson (JNJ) has initiated the process of selling shares of its consumer-healthcare business – WSJ reports.

“The goal is to raise $3.5 billion or more in the offering at a valuation close to $40 billion.”